Alvogen and Lotus Announce First to Launch Generic Version of Navelbin…
뉴스와이어신상품
0
743
0
2019.08.02 18:58
Alvogen today announced that its subsidiary Lotus Pharmaceuticals has launched Vinorelbine 20, 30 and 80mg soft capsules in Europe. The product is the generic version of Pierre Fabre M?dicament’s Navelbine®, which is indicated for the treatment of advanced non-small-cell lung cancer (NSCLC) and advanced breast cancer. The product is the first launch of a generic version of Navelbine® in Europe.
Alvogen and its business partners are first to market with Vinorelbine softgel capsules in Eur...